Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know
- PMID: 32193642
- DOI: 10.1007/s00330-020-06700-4
Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know
Abstract
The acquisition of adequate tumor sample is required to verify primary tumor type and specific biomarkers and to assess response to therapy. Historically, invasive surgical procedures were the standard methods to acquire tumor samples until advancements in imaging and minimally invasive equipment facilitated the paradigm shift image-guided biopsy. Image-guided biopsy has improved sampling yield and minimized risk to the patient; however, there are still limitations, such as its invasive nature and its consequent limitations to longitudinal tumor monitoring. The next paradigm shift in sampling technique will need to address these issues to provide a more reliable and less invasive technique. Recently, liquid biopsy (LB) has emerged as a non-invasive alternative to tissue sampling. This technique relies on direct sampling of blood or other bodily fluids in contact with the tumor in order to collect circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and circulating RNAs-in particular microRNA (miRNAs). Clinical applications of LB involve different steps of cancer patient management including screening, detection of disease recurrence, and evaluation of acquired resistance. With any paradigm shift, old techniques are often relegated to a secondary option. Although image-guided biopsies may appear as a passive spectator on the rapid advancement of LB, the two techniques may well be codependent. Interventional radiology may be integral to directly sample the liquid surrounding or draining from the tumor. In addition, LB may help to correctly select the patients for image-guided loco-regional treatments, to determine its treatment endpoint, and to early detect recurrence. KEY POINTS: • Liquid biopsy is a novel technology with potential high impact in the management of patients undergoing image-guided procedures. • Interventional radiology procedures may increase liquid biopsy sensitivity through direct fluid sampling. • Liquid biopsy techniques may provide a venue for improving patients' selection and enhance outcomes of interventional loco-regional therapies performed by interventional radiologists.
Keywords: Biomarker; Image-guided biopsy; Interventional radiology; Liquid biopsy; Thermal ablation.
Similar articles
-
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21. Clin Orthop Relat Res. 2025. PMID: 38905450
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
MRI software and cognitive fusion biopsies in people with suspected prostate cancer: a systematic review, network meta-analysis and cost-effectiveness analysis.Health Technol Assess. 2024 Oct;28(61):1-310. doi: 10.3310/PLFG4210. Health Technol Assess. 2024. PMID: 39367754 Free PMC article.
-
Current status of circulating tumor DNA and circulating cell alterations in HPV-associated head and neck cancer.Oral Oncol. 2025 Aug;167:107417. doi: 10.1016/j.oraloncology.2025.107417. Epub 2025 Jun 13. Oral Oncol. 2025. PMID: 40516153 Review.
-
Identification of Somatic Genetic Variants in Superficial Vascular Malformations by Liquid Biopsy in a Cohort of 88 Patients from a French Hospital.Mol Diagn Ther. 2025 May;29(3):367-380. doi: 10.1007/s40291-025-00770-0. Epub 2025 Feb 3. Mol Diagn Ther. 2025. PMID: 39899252
Cited by
-
Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin.Cancers (Basel). 2021 May 26;13(11):2617. doi: 10.3390/cancers13112617. Cancers (Basel). 2021. PMID: 34073585 Free PMC article. Review.
-
Microfluidic Approaches and Methods Enabling Extracellular Vesicle Isolation for Cancer Diagnostics.Micromachines (Basel). 2022 Jan 16;13(1):139. doi: 10.3390/mi13010139. Micromachines (Basel). 2022. PMID: 35056304 Free PMC article. Review.
-
Clinical value of sequential circulating tumor DNA analysis using next-generation sequencing and epigenetic modifications for guiding thermal ablation for colorectal cancer metastases: a prospective study.Radiol Med. 2024 Oct;129(10):1530-1542. doi: 10.1007/s11547-024-01865-0. Epub 2024 Aug 25. Radiol Med. 2024. PMID: 39183242
References
-
- Prud’homme C, Deschamps F, Allorant A et al (2018) Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): what are the real risks? Eur J Cancer 103:108–119 - PubMed
-
- Overman MJ, Modak J, Kopetz S et al (2013) Use of research biopsies in clinical trials: are risks and benefits adequately discussed? J Clin Oncol 31:17–22 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical